![](/page/web/0014/static/images/nopic.png)
Zepp Health Corporation Announces Board Changes
MILPITAS,Calif.,Sept. 3,2024-- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP),a global leader in smart wearables and health technology,today announced that i
MILPITAS,Calif.,Sept. 3,2024-- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP),a global leader in smart wearables and health technology,today announced that i
LONDON,Sept. 3,2024-- Morphy Richards,a leading innovator and trusted name in home appliances,proudly announces the launch of the world\'s first ductless portable air conditioner. Engineered with the
HONG KONG,Sept. 4,2024-- CNOOC Limited (the "Company",SEHK: 00883 (HKD Counter) and 80883 (RMB Counter),SSE: 600938) announces today that Wushi 17-2 Oilfields Development Project has commen
SAN FRANCISCOand SUZHOU,China,Sept. 2,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua
SINGAPORE,Sept. 2,2024--Digital travel platform Agoda has revealed an increasing number of Malaysians are searching for international travel for the upcoming Malaysia Day long weekend. Agoda data sho
CHANGZHOU,China,Sept. 2,2024-- Trinasolar published its financial report for the first half of 2024 on Aug 30,reporting revenue of $6.047 billion and net profit attributable to the parent of $74.058 m
Driven by rapid user growth and strong financial performance,thefintech platform is cementing its position in the real estate debt investment sector with strategic backing from Aspial Corporation Limi
SINGAPORE,Aug. 28,2024--Singapore-based global technology company,CrimsonLogic,part of PSA International,and a leader in digital solutions for businesses and governments,announced today a strategic pa
SINGAPORE,Aug. 28,2024-- Global Trade Review (GTR) is proud to announce GTR Asia 2024,set to take place on September 3-4 at the iconic Sands Expo and Convention Centre in Singapore. Celebrating its 15
Partnership seeks to identify rheumatoid arthritis biomarkers to improve understanding of disease risk,progression,and treatment responses